København, Denmark

Niels Peter Hundahl Møller


Average Co-Inventor Count = 13.3

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Copenhagen, DK (2005)
  • København, DK (2006)
  • København Ø, DK (2006)

Company Filing History:


Years Active: 2005-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Niels Peter Hundahl Møller: Innovator in Protein Tyrosine Phosphatase Research

Introduction

Niels Peter Hundahl Møller is a distinguished inventor based in København, Denmark. He has made significant contributions to the field of biochemistry, particularly in the area of Protein Tyrosine Phosphatases (PTPases). With a total of 3 patents to his name, Møller's work has implications for various diseases, including diabetes and cancer.

Latest Patents

Møller's latest patents include a method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4. This invention provides a method for inhibiting members of the PTPase family, which can be crucial in managing autoimmune diseases, inflammation, and diabetes. Another notable patent involves novel compounds that serve as pharmacologically useful inhibitors of PTPases, aimed at treating type I and type II diabetes, insulin resistance, and obesity.

Career Highlights

Møller is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk focuses on developing innovative treatments that target metabolic diseases. His research has been instrumental in advancing our understanding of PTPases and their role in various health conditions.

Collaborations

Møller has collaborated with notable colleagues such as Henrik Sune Andersen and Ole Hvilsted Olsen. These collaborations have further enriched his research and contributed to the development of effective therapeutic strategies.

Conclusion

Niels Peter Hundahl Møller is a prominent figure in the field of biochemistry, with a focus on Protein Tyrosine Phosphatases. His innovative patents and work at Novo Nordisk highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…